• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

MeiraGTx Holdings plc (MGTX)

Ordinary Shares
Sell: $8.75|Buy: $9.75|Change: 0.12 (-1.26%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Address

92 Britannia Walk
London
CYM
N1 7NQ

Website

https://www.meiragtx.com

Sector 

Healthcare

Forecast key dates

NameKey Date
MeiraGTx Holdings PLC Annual Report for 20262027-03-30T00:00:00
MeiraGTx Holdings PLC Fourth Quarter Earnings Results for 20262027-03-26T00:00:00
MeiraGTx Holdings PLC Third Quarter Earnings Results for 20262026-11-13T00:00:00
MeiraGTx Holdings PLC Second Quarter Earnings Results for 20262026-08-14T00:00:00
MeiraGTx Holdings PLC Annual General Meeting for 20262026-06-12T10:00:00
MeiraGTx Holdings PLC First Quarter Earnings Results for 20262026-05-13T00:00:00

Previous key dates

NameKey Date
MeiraGTx Holdings PLC Annual Report for 20252026-03-30T00:00:00
MeiraGTx Holdings PLC Fourth Quarter Earnings Results for 20252026-03-26T00:00:00
MeiraGTx Holdings PLC Third Quarter Earnings Results for 20252025-11-13T00:00:00
MeiraGTx Holdings PLC Second Quarter Earnings Results for 20252025-08-14T00:00:00
MeiraGTx Holdings PLC Annual General Meeting for 20252025-06-12T10:00:00
46th Annual Goldman Sachs Global Healthcare Conference2025-06-09T10:00:00
2025 Bank of America Health Care Conference2025-05-14T08:55:00
MeiraGTx Holdings PLC First Quarter Earnings Results for 20252025-05-13T00:00:00
2025 RBC Capital Makets Ophthalmology Conference2025-04-03T11:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.